Company / Current Assets
Biogen Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$9.0B
FY2025
5-year range
$6.9B / $9.8B
FY2021-FY2025
Trend
+20.3%
vs FY2024
Sector context
#13 of 215
Health Care
What the data says
Among 215 Health Care companies, Biogen is in the top 6% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $6.9B in FY2023 to $9.8B in FY2022.
Based on SEC 10-K filings.
$9.0B in FY2025 with a 5-year CAGR of +5.4%. Top quartile in the Health Care sector.
Improved from $6.9B to $9.0B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -2.9%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 215This company $9.0B Sector average $2.5B
▼
+254.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.4%, indicating consistent growth.
- In FY2025, current assets increased 20.3% year-over-year.
- Ranks #13 out of 215 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.0B | +20.3% |
| FY2024 | $7.5B | +8.7% |
| FY2023 | $6.9B | -29.9% |
| FY2022 | $9.8B | +24.6% |
| FY2021 | $7.9B | +14.1% |
| FY2020 | $6.9B | -17.8% |
| FY2019 | $8.4B | +9.7% |
| FY2018 | $7.6B | -3.0% |
| FY2017 | $7.9B | -9.8% |
| FY2016 | $8.7B | +30.3% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026